These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-002122-22 A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for treatme... 2009-03-19 due-trials
Not reported 2006-000692-15 A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers 2008-03-20 due-trials
Not reported 2006-001415-29 A phase IIa uncontrolled study to evaluate hair growth in subjects with male-pattern baldness using a cell suspension of expanded autologous dermal papilla cells (ICX-TRC). 2009-02-11 due-trials
Not reported 2006-003639-59 A phase IIa open-label dose-escalation study using ICX-RHY to enhance the aesthetic appearance of nasolabial folds 2008-05-08 due-trials
Not reported 2006-006443-30 A phase IIa open-label study using ICX-RHY to enhance the aesthetic appearance of facial skin imperfections. 2008-05-23 due-trials
Not reported 2010-023121-38 A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa. 2012-09-20 due-trials